Compounds > cysteamine
Page last updated: 2024-08-17

cysteamine and Broad Beta Disease

cysteamine has been researched along with Broad Beta Disease in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19905 (83.33)18.7374
1990's1 (16.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fisher, EA; Gahl, WA1
Innerarity, TL; Mahley, RW; Weisgraber, KH1
Brewer, HB; Ghiselli, G; Gregg, RE1
Hiramori, K; Nambu, S; Nishioeda, Y; Sumiyoshi, T; Yamamoto, A; Yamamura, T1
Frants, RR; Havekes, LM; Hoffer, MJ; Kibirige, MS; Naoumova, RP; Niththyananthan, S; Thompson, GR1
Fisher, E; Gahl, WA; Gregg, RE; Hoeg, JM1

Other Studies

6 other study(ies) available for cysteamine and Broad Beta Disease

ArticleYear
Cysteamine in treatment of type III hyperlipidaemia?
    Lancet (London, England), 1982, Nov-20, Volume: 2, Issue:8308

    Topics: Animals; Cysteamine; Disease Models, Animal; Humans; Hyperlipoproteinemia Type III; Lipoproteins, VLDL; Receptors, Cell Surface; Receptors, Lipoprotein

1982
Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site.
    The Journal of biological chemistry, 1982, Mar-10, Volume: 257, Issue:5

    Topics: Apolipoproteins; Apolipoproteins E; Arginine; Cysteamine; Cysteine; Homozygote; Humans; Hyperlipoproteinemia Type III; Kinetics; Lipoproteins, LDL; Receptors, Cell Surface; Receptors, LDL

1982
Apolipoprotein E Bethesda. Isolation and partial characterization of a variant of human apolipoprotein E isolated from very low density lipoproteins.
    Biochimica et biophysica acta, 1984, Jul-06, Volume: 794, Issue:2

    Topics: Aged; Apolipoprotein E2; Apolipoproteins; Apolipoproteins E; Cysteamine; Electrophoresis, Polyacrylamide Gel; Female; Humans; Hyperlipoproteinemia Type III; Immunodiffusion; Isoelectric Focusing; Lipoproteins, VLDL; Male; Phenotype

1984
New mutants of apolipoprotein E associated with atherosclerotic diseases but not to type III hyperlipoproteinemia.
    The Journal of clinical investigation, 1984, Volume: 74, Issue:4

    Topics: Antigen-Antibody Reactions; Apolipoproteins E; Arteriosclerosis; Cysteamine; Female; Gene Frequency; Humans; Hyperlipoproteinemia Type III; Lipoproteins, VLDL; Male; Mutation; Neuraminidase; Phenotype; Precipitin Tests

1984
Apolipoprotein E1-Hammersmith (Lys146-->Asn;Arg147-->Trp), due to a dinucleotide substitution, is associated with early manifestation of dominant type III hyperlipoproteinaemia.
    Atherosclerosis, 1996, Aug-02, Volume: 124, Issue:2

    Topics: Adult; Anticholesteremic Agents; Apolipoproteins E; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Cysteamine; Dinucleotide Repeats; DNA; Electrophoresis; Exons; Female; Fenofibrate; Genotype; Humans; Hyperlipoproteinemia Type III; Hypolipidemic Agents; Immunoblotting; Male; Nuclear Family; Phenotype; Point Mutation; Radiation-Protective Agents; Triglycerides

1996
In vivo alteration of a mutant human protein using the free thiol cysteamine.
    American journal of medical genetics, 1985, Volume: 20, Issue:2

    Topics: Apolipoprotein E2; Apolipoprotein E3; Apolipoproteins E; Child, Preschool; Cysteamine; Cystinosis; Humans; Hyperlipoproteinemia Type III; Isoelectric Focusing; Male; Middle Aged; Mutation

1985